Wadström Benjamin Nilsson, Borges Maria Carolina, Wulff Anders Berg, Smith George Davey, Sanderson Eleanor, Nordestgaard Børge Grønne
Medical Research Council (MRC) Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom; Department of Clinical Biochemistry, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark; The Copenhagen General Population Study, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Medical Research Council (MRC) Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
J Am Coll Cardiol. 2025 Apr 1;85(12):1353-1368. doi: 10.1016/j.jacc.2024.12.033.
Elevated remnant cholesterol and low-density lipoprotein (LDL) cholesterol both increase the risk of coronary artery disease (CAD), but it is not known if the same is true for peripheral artery disease (PAD).
This study tested the hypothesis that elevated remnant cholesterol and LDL cholesterol, each independent of the other, have causal effects on risk of PAD.
The authors constructed genetic scores from variants near genes known to directly affect levels of remnant cholesterol and LDL cholesterol, identified through a genome-wide association study of individuals in the UK Biobank. Univariable (remnant cholesterol and LDL cholesterol genetic scores separately) and multivariable (remnant cholesterol and LDL cholesterol genetic scores combined) Mendelian randomization were used to estimate the causal effects of higher remnant cholesterol and LDL cholesterol levels on ORs for PAD (n = 38,414 cases and 758,308 controls) and CAD (n = 221,445 cases and 770,615 controls).
Increments in remnant and LDL genetic scores corresponding to 1 mmol/L (39 mg/dL) higher remnant and LDL cholesterol, respectively, were associated with univariable ORs for PAD of 2.72 (95% CI: 2.10-3.52) and 1.37 (95% CI: 1.25-1.51); corresponding multivariable ORs were 2.16 (95% CI: 1.49-3.12) and 1.14 (95% CI: 1.00-1.30). For CAD, corresponding univariable ORs were 2.92 (95% CI: 2.34-3.64) and 1.67 (95% CI: 1.56-1.79), whereas multivariable ORs were 1.86 (95% CI: 1.39-2.47) and 1.44 (95% CI: 1.29-1.60). Scaled to 1 SD increments in remnant cholesterol and LDL cholesterol, corresponding univariable ORs were 1.37 (95% CI: 1.27-1.49) and 1.29 (95% CI: 1.20-1.39) for PAD, and 1.40 (95% CI: 1.31-1.51) and 1.51 (95% CI: 1.43-1.59) for CAD; corresponding multivariable ORs were 1.28 (95% CI: 1.14-1.43) and 1.11 (95% CI: 1.00-1.23) for PAD, and 1.22 (95% CI: 1.11-1.33) and 1.34 (95% CI: 1.23-1.46) for CAD.
Elevated remnant cholesterol had a causal effect on risk of PAD even after accounting for elevated LDL cholesterol, whereas most of the causal effect of elevated LDL cholesterol on risk of PAD was dependent on simultaneously elevated remnant cholesterol. These results indicate that remnant cholesterol may be the major cholesterol fraction responsible for increased risk of PAD. Future studies should investigate the biological mechanisms behind these findings to find improved therapies for prevention and treatment of PAD.
残余胆固醇和低密度脂蛋白(LDL)胆固醇升高均会增加冠状动脉疾病(CAD)风险,但外周动脉疾病(PAD)是否如此尚不清楚。
本研究检验了以下假设,即残余胆固醇和LDL胆固醇升高各自独立地对PAD风险具有因果效应。
作者通过对英国生物银行个体进行全基因组关联研究,从已知直接影响残余胆固醇和LDL胆固醇水平的基因附近的变异构建遗传评分。采用单变量(分别为残余胆固醇和LDL胆固醇遗传评分)和多变量(残余胆固醇和LDL胆固醇遗传评分合并)孟德尔随机化来估计较高的残余胆固醇和LDL胆固醇水平对PAD(n = 38,414例病例和758,308例对照)和CAD(n = 221,445例病例和770,615例对照)比值比(OR)的因果效应。
残余和LDL遗传评分分别增加相当于残余胆固醇和LDL胆固醇升高1 mmol/L(39 mg/dL),与PAD的单变量OR分别为2.72(95%CI:2.10 - 3.52)和1.37(95%CI:1.25 - 1.51)相关;相应的多变量OR分别为2.16(95%CI:1.49 - 3.12)和1.14(95%CI:1.00 - 1.30)。对于CAD,相应的单变量OR分别为2.92(95%CI:2.9(此处原文有误,应为2.34) - 3.64)和1.67(95%CI:1.56 - 1.79),而多变量OR分别为1.86(95%CI:1.39 - 2.47)和1.44(95%CI:1.29 - 1.60)。按残余胆固醇和LDL胆固醇升高至1个标准差增量进行换算,PAD相应的单变量OR分别为1.37(95%CI:1.27 - 1.49)和1.29(95%CI:1.20 - 1.39),CAD为1.40(95%CI:1.31 - 1.51)和1.51(95%CI:1.43 - 1.59);PAD相应的多变量OR分别为1.28(95%CI:1.14 - 1.43)和1.